QUANTON
Live / Registered — Registered — Section 71 accepted (as of 06 May 2026)
What this means for you
Registered since 26 Jan 2016. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 26 Jan 2036: the §71 ten-year affidavit of use).
Record
- Serial number
- 79158317
- Registration number
- 4890835
- Mark type
- Word mark
- Filed
- 29 Sept 2014
- Published for opposition
- 10 Nov 2015
- Registered
- 26 Jan 2016
- Next maintenance filing
- §71 ten-year affidavit of use, due by 26 Jan 2036 (grace period to 26 Jul 2036)
- Attorney of record
- GABRIELLE S. ROTH
Goods and services
- Class 005 — Pharmaceuticals: [ Diagnostic reagents for medical purposes; Diagnostic chemical reagents for medical purposes; ] Diagnostic chemical preparations for medical purposes, namely, for diagnosing and monitoring gastroenterological diseases, inflammatory bowel syndrome, inflammatory bowel disease, colitis ulcerosa, Morbus Crohn and for monitoring the effects of TNF-blocker on these conditions; [ diagnostic preparations for medical or veterinary purposes; ] diagnostic preparations for medical purposes [ ; diagnostic preparations for pharmaceutical purposes; reagents for in vitro laboratory tests for medical purposes; reagents for in vitro laboratory use for veterinary purposes ]
- Class 009 — Scientific and electric apparatus: [ Computer software for creating searchable databases containing information and data; ] computer software in the nature of a mobile application for use with immunochromatographic devices that test for a specific protein or antigen in a sample of body fluid or stool, and for which the software converts the analytical result to information that can be read by patients and physicians, using mobile phones or smart phones, once calibration data is downloaded from a global computer network; production lot encoded immunochromatographic devices that test for the presence of a specific protein or antigen in a sample of body fluid or stool which is converted to an analytical result that can be read by patients and physicians, using mobile phones or smart phones, once calibration data is downloaded from a global computer network; patient encoded immunochromatographic devices that determine the level of an antigen in a test sample, the results of which can be transmitted through use of a mobile app to a medical advisor, physician or doctor using a mobile phone or smart phone; machine readable immunochromatographic devices, namely, handheld immunochromatographic devices which produce test results that use a mobile app to scan and evaluate the results
- Class 042 — Scientific and technological services: [ Biological research, clinical and medical research; ] design and programming of computer software in the medical field [ ; services of a chemical and biological laboratory; analysis of human sera for medical research; medical and pharmaceutical research services ]
Owner
- Immundiagnostik AG, Bensheim, DE
- Immundiagnostik AG, DE
- Immundiagnostik AG, DE
Prosecution history
- 06 May 2026 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 06 May 2026 — REGISTERED-SEC.71 ACCEPTED
- 04 May 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 13 Jan 2026 — TEAS SECTION 71 RECEIVED
- 21 Nov 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 26 Jan 2025 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 17 Oct 2024 — INTERNATIONAL REGISTRATION RENEWED
- 25 Sept 2023 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 21 Aug 2023 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 21 Aug 2023 — INVALIDATION PROCESSED
- 25 Jul 2023 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 25 Nov 2022 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 25 Nov 2022 — REGISTERED-SEC.71 ACCEPTED
- 22 Nov 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 08 Jun 2022 — TEAS SECTION 71 RECEIVED